Medrobotics Announces Appointment Of Shawn Wery As Vice President of Clinical-Regulatory Affairs

May 11, 2011 - Medrobotics Corporation is pleased to announce the appointment of Shawn Wery to lead the Company's Clinical and Regulatory Affairs worldwide. Mr. Wery was recently promoted to this position after bringing over fifteen years clinical and regulatory experience in both publicly traded medical device companies such as Medtronic, Guidant, Boston Scientific, J&J and most recently at innovative medical device start-up Cyberkinetics.  He has considerable experience managing and developing clinical and regulatory strategies for a diverse range of products including cardiac pacemakers, stents, neurosurgical monitoring, spinal cord regeneration therapeutics and neural prosthesis.  Mr. Wery holds an MS in Exercise Physiology from The University of Michigan where he designed proprietary products and supervised research for the Departments of Gerontology and Thoracic Surgery.

Mr. Wery's appointment coincides with the Company's near term plans of seeking regulatory approval in several countries around the world to commercialize its products.

About Medrobotics Corporation.

Medrobotics Corporation has built several generations of flexible robot platforms, which are highly articulated multi-linked robots that enable surgeons to perform minimally invasive procedures for many parts of the anatomy that are otherwise difficult or previously impossible to reach from a single access site. Our product provides a precise and stable platform for enhanced visualization, and enables two-handed dexterity with instruments having tactile feedback.

The Company employs a team of professionals at its facility in New England and is expected to be commercialized in 2012.